These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19675337)

  • 1. Dipyridamole plus aspirin and hemodialysis graft patency.
    Weale AR; Cooper DG
    N Engl J Med; 2009 Aug; 361(7):720; author reply 721. PubMed ID: 19675337
    [No Abstract]   [Full Text] [Related]  

  • 2. Dipyridamole plus aspirin and hemodialysis graft patency.
    Hentschel DM
    N Engl J Med; 2009 Aug; 361(7):720-1; author reply 721. PubMed ID: 19681176
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet therapy and vascular-access patency.
    Lok CE
    N Engl J Med; 2009 May; 360(21):2240-2. PubMed ID: 19458370
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dipyridamole plus aspirin on hemodialysis graft patency.
    Dixon BS; Beck GJ; Vazquez MA; Greenberg A; Delmez JA; Allon M; Dember LM; Himmelfarb J; Gassman JJ; Greene T; Radeva MK; Davidson IJ; Ikizler TA; Braden GL; Fenves AZ; Kaufman JS; Cotton JR; Martin KJ; McNeil JW; Rahman A; Lawson JH; Whiting JF; Hu B; Meyers CM; Kusek JW; Feldman HI;
    N Engl J Med; 2009 May; 360(21):2191-201. PubMed ID: 19458364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of platelet inhibitory therapy on prosthetic graft maturation.
    Bearn PE; Moffat C; Seddon AM; Bull H; Marston A; Fox B; McCollum CN
    Int J Exp Pathol; 1993 Feb; 74(1):1-8. PubMed ID: 8471529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN; Goldman M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of aspirin in enhancing arterial graft patency.
    Clowes AW
    J Vasc Surg; 1986 Feb; 3(2):381-5. PubMed ID: 3511307
    [No Abstract]   [Full Text] [Related]  

  • 8. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft.
    Nee R; Parker AL; Little DJ; Yuan CM; Himmelfarb J; Lowe SR; Abbott KC
    Clin Nephrol; 2014 Jan; 81(1):38-51. PubMed ID: 24161074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting.
    Duran E; Canbaz S; Ege T; Acipayam M
    Platelets; 2001 Dec; 12(8):503-4. PubMed ID: 11798400
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study.
    Sreedhara R; Himmelfarb J; Lazarus JM; Hakim RM
    Kidney Int; 1994 May; 45(5):1477-83. PubMed ID: 8072261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole plus aspirin in cerebrovascular disease.
    Cohen SN
    Arch Neurol; 2000 Jul; 57(7):1086-7. PubMed ID: 10892000
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal duration of antiplatelet therapy after implantation of a small-diameter polytetrafluoroethylene arterial prosthesis.
    Nordestgaard AG; Moller LP; Marcus CS; Wilson SE
    Curr Surg; 1987; 44(6):490-3. PubMed ID: 3428002
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aspirin associates with longer primary patency of hemodialysis grafts.
    Dixon BS; Beck GJ; Dember LM; Vazquez MA; Greenberg A; Delmez JA; Allon M; Himmelfarb J; Hu B; Greene T; Radeva MK; Davidson IJ; Ikizler TA; Braden GL; Lawson JH; Cotton JR; Kusek JW; Feldman HI;
    J Am Soc Nephrol; 2011 Apr; 22(4):773-81. PubMed ID: 21415156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and arteriovenous graft thrombosis in hemodialysis: just what the doctor ordered?
    Bech FR; Chertow GM
    J Am Soc Nephrol; 2011 Apr; 22(4):595-7. PubMed ID: 21415154
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
    Rosenthal D; Mittenthal MJ; Ruben DM; Jones DH; Estes JW; Stanton PE; Lamis PA
    Am Surg; 1987 Sep; 53(9):477-81. PubMed ID: 3631756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
    Dalton B; Papoushek C; Evans MF
    Can Fam Physician; 2001 Nov; 47():2235-9. PubMed ID: 11768921
    [No Abstract]   [Full Text] [Related]  

  • 20. Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
    Dixon BS; Beck GJ; Dember LM; Depner TA; Gassman JJ; Greene T; Himmelfarb J; Hunsicker LG; Kaufman JS; Lawson JH; Meyers CM; Middleton JP; Radeva M; Schwab SJ; Whiting JF; Feldman HI;
    Clin Trials; 2005; 2(5):400-12. PubMed ID: 16317809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.